Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/04/1997 | US5684149 Cyclic alkylenetetramines with metals as catalysts |
11/04/1997 | US5684147 Therapeutic anti-HIV anti-viral oligonucleotides and pharmaceutical formulations thereof |
11/04/1997 | US5684146 DNA coding for variable region to human influenza A type virus |
11/04/1997 | US5684145 Carrier system against GNRH |
11/04/1997 | US5684144 Escherichia coli csrA gene, protein encoded thereby, and methods of use thereof |
11/04/1997 | US5684134 Antibody specific for β1→6 N-acetylglucosamininyltransferase |
11/04/1997 | US5684133 Neurite growth regulatory factors, antibodies thereto, and pharmaceutical compositions |
11/04/1997 | US5684126 Ebnerin: a secreted von Ebner's gland protein associated with taste buds |
11/04/1997 | US5683988 Anti-sense oligodeoxynucleotide to fibrogenic cytokine TGF-β and use thereof |
11/04/1997 | US5683987 Multidrug resistance phenotypes and nucleotide sequences |
11/04/1997 | US5683985 Oligonucleotide decoys and methods relating thereto |
11/04/1997 | US5683913 Genetic engineering using rhodococcus transformant |
11/04/1997 | US5683912 Dna and genetic engineering |
11/04/1997 | US5683910 Human phosphorylase kinase gamma subunit |
11/04/1997 | US5683909 Genetic engineering of microorganisms |
11/04/1997 | US5683905 Vectors and cell lines capable of correctly splicing exon regions |
11/04/1997 | US5683904 Isolated dna encoding protease |
11/04/1997 | US5683903 Attachment enhanced 293 cells |
11/04/1997 | US5683902 Human papilloma virus inhibition by a hairpin ribozyme |
11/04/1997 | US5683901 Method of producing RNA viruses from cDNA |
11/04/1997 | US5683900 Pasteurella haemolytica PhaI restriction endonuclcape and methyltranstesase |
11/04/1997 | US5683899 Methods and compositions for combinatorial-based discovery of new multimeric molecules |
11/04/1997 | US5683894 Recombinant nerve growth factor |
11/04/1997 | US5683893 Mutant AOX2 promoter, vector carrying same, transformant, and production of heterlogous protein |
11/04/1997 | US5683891 Method for producing exogenous protein |
11/04/1997 | US5683890 Bacteriocins from Streptococcus thermophilus |
11/04/1997 | US5683886 Tumor rejection antigens which correspond to amino acid sequences in tumor rejection antigen precursor bage, and uses thereof |
11/04/1997 | US5683884 Incubation of eukarotic cells with transformed or transfected with dna sequences for gene expression |
11/04/1997 | US5683883 Hybridizing oligonucleotide primer to single-stranded target dna, amplification, denaturing |
11/04/1997 | US5683879 Methods for producing a single stranded polydeoxynucleotide having two different defined sequences and kits |
11/04/1997 | US5683878 Medical diagnosis using dna and rna and transcription |
11/04/1997 | US5683874 Single-stranded circular oligonucleotides capable of forming a triplex with a target sequence |
11/04/1997 | US5683873 EGS-mediated inactivation of target RNA |
11/04/1997 | US5683868 Genetically engineered e. coli, bioluminescence |
11/04/1997 | US5683867 Nucleic acid ligands, blending, partitioning and amplification |
11/04/1997 | US5683866 Proteins fron sendai viruses formed by incubation |
11/04/1997 | US5683865 Method for diagnosis of mystery swine disease |
11/04/1997 | US5683700 Immunization using an attenuated salmonella bacterium containing an nirb promoter linked to a dna sequence encoding a heterologous protein |
11/04/1997 | US5683696 Cloning of duffy blood group antigen, gpD |
11/04/1997 | US5683693 Method for inducing T cell unresponsiveness to a tissue or organ graft with anti-CD40 ligand antibody or soluble CD40 |
11/04/1997 | US5683691 Bacillus thuringiensis insecticidal toxins |
11/04/1997 | US5683688 Unglycosylated recombinant human lymphotoxin polypeptides and compositions |
11/04/1997 | CA2116110C New cell lines which support replication of baculoviruses |
11/04/1997 | CA1339526C Recombinant myco-bacterial expression vehicles and uses therefor |
11/03/1997 | CA2204332A1 Nucleic acid constructs containing genes encoding transport signals |
10/31/1997 | CA2175435A1 Proteins involved in the synthesis and assembly of o-antigen in pseudomonas aeruginosa |
10/30/1997 | WO1997040462A2 Correlating polymorphic forms with multiple phenotypes |
10/30/1997 | WO1997040458A2 Universal solid supports and methods for their use |
10/30/1997 | WO1997040385A1 Light-controlled electrokinetic assembly of particles near surfaces |
10/30/1997 | WO1997040380A1 Leptin assay |
10/30/1997 | WO1997040193A2 Method for typing and detecting hbv |
10/30/1997 | WO1997040192A1 Novel protein - traf6 |
10/30/1997 | WO1997040191A1 Method for simultaneous detection of multiple fluorophores for in situ hybridization |
10/30/1997 | WO1997040190A1 Heteroduplex tracking assay (hta) for genotyping hcv |
10/30/1997 | WO1997040189A1 HIGH VOLUME IN-SITU mRNA HYBRIDIZATION METHOD FOR THE QUANTIFICATION AND DISCOVERY OF DISEASE SPECIFIC GENES |
10/30/1997 | WO1997040187A1 Diagnostic method and apparatus |
10/30/1997 | WO1997040186A1 Detection of variations in human h2 receptors |
10/30/1997 | WO1997040185A1 Identification of numerical changes in cell dna |
10/30/1997 | WO1997040184A1 Method, apparatus and kits for sequencing of nucleic acids using multiple dyes |
10/30/1997 | WO1997040183A2 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
10/30/1997 | WO1997040182A1 Genetically transfected human dendritic cells, their production and use, preferably as vaccines |
10/30/1997 | WO1997040181A1 Analyte assay using particulate labels |
10/30/1997 | WO1997040180A1 Chicken embryo lethal orphan (celo) virus |
10/30/1997 | WO1997040179A1 Genetic constructs and methods for producing fruits with very little or diminished seed |
10/30/1997 | WO1997040178A1 Monitoring of transgenic plants with in vivo markers |
10/30/1997 | WO1997040177A1 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens |
10/30/1997 | WO1997040176A1 Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen |
10/30/1997 | WO1997040175A1 PROCESS FOR MODIFYING THE ENZYME 7β-(4-CARBOXYBUTANAMIDO) CEPHALOSPORINACYLASE AND PURIFYING SAID ENZYME IN A SINGLE CHROMATOGRAPHIC STEP |
10/30/1997 | WO1997040174A1 Mammalian hyaluronan synthases, nucleic acids, uses thereof |
10/30/1997 | WO1997040173A2 Pi 3-kinase fusion mutants and uses thereof |
10/30/1997 | WO1997040172A1 Derived tyrosine hydroxylase gene expression system |
10/30/1997 | WO1997040171A1 Process for producing the enzyme d-aminoacido oxydase of rhodotorula gracilis in host cells |
10/30/1997 | WO1997040170A2 Functional expression of heterologous adenylyl cyclase |
10/30/1997 | WO1997040169A1 Non antibiotic selectable markers for live vaccines |
10/30/1997 | WO1997040168A1 Hepatitis g virus protease |
10/30/1997 | WO1997040167A1 Porcine retrovirus |
10/30/1997 | WO1997040166A2 Simian-human hav having a chimeric 2c protein |
10/30/1997 | WO1997040165A1 Novel human cytomegalovirus dna constructs and uses therefor |
10/30/1997 | WO1997040164A1 Hepatitis b monoclonal antibodies |
10/30/1997 | WO1997040163A1 Nucleic acid vaccination for parvoviral infections |
10/30/1997 | WO1997040162A2 Pesticidal toxins |
10/30/1997 | WO1997040161A1 Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability |
10/30/1997 | WO1997040160A1 A prokaryotic protein having functional and structural homology with the human p-glycoprotein encoded by the mdr-1 gene, nucleic acids encoding and cells expressing said protein |
10/30/1997 | WO1997040159A1 Characterization of transfer factors and methods of use |
10/30/1997 | WO1997040158A1 Epimorphin antagonist and process for producing the same |
10/30/1997 | WO1997040157A1 Matrix metalloprotease |
10/30/1997 | WO1997040156A1 Mutated ras peptides for generation of cd8+ cytotoxic t lymphocytes |
10/30/1997 | WO1997040155A1 Protein mediating neuronal-glial interaction, dna encoding the same, and methods of use thereof |
10/30/1997 | WO1997040154A1 Type c lectins |
10/30/1997 | WO1997040153A1 Al-2 neurotrophic factor |
10/30/1997 | WO1997040152A1 Glial cell line-derived neurotrophic factor receptor |
10/30/1997 | WO1997040151A2 Secreted proteins and polynucleotides encoding them |
10/30/1997 | WO1997040150A1 Novel proteins c16 and c16n or genes encoding the same |
10/30/1997 | WO1997040149A1 Autoantigen and proteins structurally related thereto for use in immunotherapy of autoimmune diseases |
10/30/1997 | WO1997040148A2 Peptide antagonists derived from the transmembrane domains of g protein-coupled receptors |
10/30/1997 | WO1997040147A1 Antigenically reactive regions of the hepatitis a virus polyprotein |
10/30/1997 | WO1997040146A1 Yeast invertase gene as reporter system for isolating cytokines |
10/30/1997 | WO1997040145A1 Inactivation resistant factor viii |
10/30/1997 | WO1997040143A1 Apoptosis inducing protein and gene encoding the same |
10/30/1997 | WO1997040142A1 Modified ligands of calcium-dependent binding proteins |